Demographics and Early Outcomes of Commercial Antibiotic Cement Usage for Infection Prophylaxis During Primary Total Knee Arthroplasty in Patients Older Than 65 Years: An American Joint Replacement Registry Study.
Benjamin F RicciardiKimberly R PorterThomas G MyersJohn G GinnettiNathan KaplanCaroline P ThirukumaranPublished in: The Journal of the American Academy of Orthopaedic Surgeons (2023)
The use of commercial ALBC in patients older than 65 years for primary TKA in the AJRR was not closely associated with underlying comorbidities suggesting that hospital-level and surgeon-level factors influence its use. In addition, ALBC use did not decrease the risk of 90-day revision for PJI and was not associated with 90-day readmission rates.
Keyphrases
- total knee arthroplasty
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- physical activity
- healthcare
- emergency department
- total hip
- skeletal muscle
- metabolic syndrome
- middle aged
- patient reported outcomes
- robot assisted
- weight loss
- total hip arthroplasty